Log in to save to my catalogue

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2⁺ breast cance...

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2⁺ breast cance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_854949449

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2⁺ breast cancer patients

About this item

Full title

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2⁺ breast cancer patients

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (9), p.3761-3766

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Clinical benefits from trastuzumab and other anti-HER2 therapies in patients with HER2 amplified breast cancer remain limited by primary or acquired resistance. To identify potential mechanisms of resistance, we established trastuzumab-resistant HER2 amplified breast cancer cells by chronic exposure to trastuzumab treatment. Genomewide copy-number...

Alternative Titles

Full title

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2⁺ breast cancer patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_854949449

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_854949449

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1014835108

How to access this item